Concepedia

N. L. Spector

NL

Statistics

Publications

2

Citations

119

H-Index

2

Active since

2004

Affiliations

GlaxoSmithKline (United States)(Current)

N. L. Spector is an author at GlaxoSmithKline (United States) specializing in pharmacology, erbb receptor signaling, and oncology.

Publications per year

2004–2006

2

Publications

2

EGF103009, a phase II trial of lapatinib monotherapy in patients with relapsed/refractory inflammatory breast cancer (IBC): Clinical activity and biologic predictors of response

N. L. Spector, K. Blackwell, James B. Hurley et al. · Journal of Clinical Oncology · 2006 · 79 citations

Medicine, Oncology, Pharmacology +15

Clinical activity of GW572016 in EGF10003 in patients with solid tumors

M. Versola, H. A. Burris, Sharon Jones et al. · Journal of Clinical Oncology · 2004 · 40 citations

Medicine, Oncology, Pharmacology +17

1–2 of 2